ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Subgroup Okeys Carcinogenesis Testing for Anticancer Drugs

September 8, 1978

NCI Seeks Changes In CIS Funding Plan With Next Recompetition

April 24, 1987

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

In Brief: One More Committee Review Needed for L.A., Rhode Island; Animal Tests In Factories (?)

May 13, 1977

Abstracts Of Papers From Therapeutic Radiology Meeting

November 21, 1975

House Bill Seeks Coverage for Care Planning, Reviving Proposal Once Maligned By The Right

September 6, 2013